HOUSE COMMITTEE EXAMINES FLU VACCINE SHORTAGE
Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases, appears before the House Government Reform Committee to discuss the nation's flue vacine shortage on Capitol Hill in Washington on Oct. 8, 2004. The supply of flu shots was dramatically cut after a major manufacturer in Great Britain was forced to pull its vaccine due to bacterial contamination. (UPI Photo/Roger L. Wollenberg)
UPI Related News
BETHESDA, Md., Nov. 3 (UPI) -- Healthy pregnant women need only one dose of H1N1 influenza vaccine to mount a robust immune response, U.S. health officials say.
BETHESDA, Md., Oct. 12 (UPI) -- The first clinical trial of the H1N1 influenza vaccine in human immunodeficiency virus-infected pregnant women has begun, U.S. officials said.
BETHESDA, Md., July 22 (UPI) -- Preparations are under way to initiate clinical trials to test 2009 H1N1 flu vaccine candidates, U.S. health officials said Wednesday.
WASHINGTON, March 26 (UPI) -- The head of the U.S. agency in charge of AIDS research says scientists need to go back to basics to find a vaccine against the HIV virus.
SAN FRANCISCO, Feb. 11 (UPI) -- U.S. government scientists have discovered an important piece of the puzzle in their efforts to learn how the human immunodeficiency virus operates.
WASHINGTON , Jan. 9 (UPI) -- U.S. researchers said public health officials need to consider the threat of dengue reaching the United States as a real possibility.
WASHINGTON, Dec. 3 (UPI) -- A potential HIV vaccine that recently failed a clinical trial in the United States may increase some people's chance of catching the virus that causes AIDS.
WASHINGTON, April 17 (UPI) -- U.S. government scientists announced Monday they have gained a new understanding of how long-term immunity works.
WASHINGTON, Oct. 25 (UPI) -- Despite some spot shortages, U.S. federal health officials are confident the country's overall flu vaccine supply will be adequate this season.
BETHESDA, Md., Oct. 4 (UPI) -- The United States has begun stockpiling antiviral drugs and awarding contracts to develop vaccines in response to warnings of an avian influenza pandemic.
